India's Pharma Exports Surge Amid Global Uncertainties

The Indian pharmaceutical industry is experiencing significant growth in exports, with Brazil and Nigeria emerging as key destinations. The increase, noted during April-November FY26, highlights India's role as a crucial supplier to various international markets amid global economic uncertainties.

The Indian pharmaceutical sector is marking significant strides in global exports, with Brazil and Nigeria standing out as emerging key markets amidst worldwide economic challenges. Data from the commerce ministry reveals a notable growth trajectory for these regions, with Nigeria contributing USD 179 million in export increments during the first eight months of the fiscal year.

Brazil, on the other hand, recorded nearly USD 100 million in export growth, underscoring increased healthcare access and reliance on Indian generics. The overall export scenario saw a 6.5% rise to USD 20.48 billion during April-November 2025-26, according to official figures.

While the US remains the largest single destination, countries like France, the Netherlands, and South Africa are also registering steady growth. The Netherlands alone added over USD 58 million in exports, highlighting India's growing integration into European pharmaceutical networks. This diversified market reach is bolstering India's stability in the pharma export sector.

(With inputs from agencies.)